首页 | 本学科首页   官方微博 | 高级检索  
检索        

术前肝脾介入疗法在原发性肝癌伴脾亢中应用的临床研究
引用本文:黄向华,蒋松琪,李拥军,邵冰峰,江晓晖,高志斌.术前肝脾介入疗法在原发性肝癌伴脾亢中应用的临床研究[J].南通医学院学报,2007,27(4):269-270.
作者姓名:黄向华  蒋松琪  李拥军  邵冰峰  江晓晖  高志斌
作者单位:南通大学附属肿瘤医院,通州,226361
摘    要:目的:研究术前肝脾介入疗法对提高原发性肝癌伴脾亢患者手术切除率的实际效果。方法:观察术前进行肝脾双介入治疗的原发性肝癌伴脾亢患者24例在介入前后白细胞、血小板计数改变情况及介入后成功进行手术治疗的例数。结果:介入后患者白细胞、血小板计数均有上升,上升至正常范围21例,成功进行手术探查24例,肝部分切除18例,合并脾切除15例。结论:术前肝脾双介入疗法方便、安全、有效,能提高肝癌手术切除率,值得临床推广。

关 键 词:原发性肝癌  脾功能亢进  手术  介入
文章编号:1000-2057(2007)04-0269-02
收稿时间:2007-04-17
修稿时间:2007年4月17日

Clinical research of preoperative intervention of liver and spleen in the primary hepatic carcinoma
HUANG Xianghua,JIANG Songqi,LI Yongjun,et al.Clinical research of preoperative intervention of liver and spleen in the primary hepatic carcinoma[J].ACTA Academiae Medicinae Nantong,2007,27(4):269-270.
Authors:HUANG Xianghua  JIANG Songqi  LI Yongjun  
Abstract:Objective: To study the practical effects of liver-spleen intervention before operation on the excision rate of primary liver cancer with excessive spleen ability. Methods: There were 24 patients with primary liver cancer and received therapeutics of liver-spleen intervention before operation. Their leucocyte and haematoblast numbers before and after the intervention were observed, and the successful cases were counted. Results: The numbers of leucocyte and haematoblast in patients after the therapeutics both rose. The data of 21 cases were in the normal range. Operation exploration was successfully made in 24 cases. Liver was partly exscinded in 18 cases. Liver in combination spleen was exscinded in 15 cases. Conclusion: Therapeutics of liver-spleen intervention before operation is convenient, safe and effective. It is able to raise excision rate and worthy to be popularized in clinic.
Keywords:Primary liver cancer  Excessive spleen ability  Operation  Intervention
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号